Atara Biotherapeutics Inc (ATRA)
10.61
-0.07
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
10.60
-0.01
(-0.09%)
After-Hours: 20:00
Atara Biotherapeutics Enterprise Value: -6.078M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -6.078M |
| November 20, 2024 | -5.674M |
| November 19, 2024 | -3.889M |
| November 18, 2024 | -1.930M |
| November 15, 2024 | 1.929M |
| November 14, 2024 | 6.364M |
| November 13, 2024 | 14.95M |
| November 12, 2024 | 0.0279M |
| November 11, 2024 | 0.6038M |
| November 08, 2024 | -2.046M |
| November 07, 2024 | -9.015M |
| November 06, 2024 | -9.562M |
| November 05, 2024 | -8.182M |
| November 04, 2024 | -0.4328M |
| November 01, 2024 | -11.45M |
| October 31, 2024 | -16.05M |
| October 30, 2024 | -12.20M |
| October 29, 2024 | -16.28M |
| October 28, 2024 | -16.50M |
| October 25, 2024 | -17.82M |
| October 24, 2024 | -18.63M |
| October 23, 2024 | -18.57M |
| October 22, 2024 | -15.24M |
| October 21, 2024 | -13.98M |
| October 18, 2024 | -13.18M |
| Date | Value |
|---|---|
| October 17, 2024 | -13.35M |
| October 16, 2024 | -14.38M |
| October 15, 2024 | -19.09M |
| October 14, 2024 | -20.41M |
| October 11, 2024 | -21.10M |
| October 10, 2024 | -22.53M |
| October 09, 2024 | -22.36M |
| October 08, 2024 | -22.19M |
| October 07, 2024 | -22.88M |
| October 04, 2024 | -23.05M |
| October 03, 2024 | -25.86M |
| October 02, 2024 | -23.51M |
| October 01, 2024 | -23.39M |
| September 30, 2024 | -20.52M |
| September 27, 2024 | 10.52M |
| September 26, 2024 | 8.170M |
| September 25, 2024 | 6.695M |
| September 24, 2024 | 7.546M |
| September 23, 2024 | 6.468M |
| September 20, 2024 | 8.908M |
| September 19, 2024 | 9.702M |
| September 18, 2024 | 9.362M |
| September 17, 2024 | 12.99M |
| September 16, 2024 | 13.50M |
| September 13, 2024 | 19.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.99M
Minimum
Nov 10 2023
1.716B
Maximum
Dec 07 2020
409.35M
Average
240.66M
Median
Feb 08 2023
Enterprise Value Benchmarks
| Azenta Inc | 1.613B |
| Perspective Therapeutics Inc | -63.40M |
| Corvus Pharmaceuticals Inc | 532.81M |
| Clearside Biomedical Inc | 53.77M |
| Quanterix Corp | 152.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.91M |
| Revenue (Quarterly) | 40.19M |
| Total Expenses (Quarterly) | 61.95M |
| EPS Diluted (Quarterly) | -2.93 |
| Gross Profit Margin (Quarterly) | 81.08% |
| Profit Margin (Quarterly) | -54.51% |
| Earnings Yield | -242.8% |
| Normalized Earnings Yield | -242.79 |